Departments of Ophthalmology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Departments of Ophthalmology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Prog Retin Eye Res. 2018 Jan;62:24-37. doi: 10.1016/j.preteyeres.2017.08.004. Epub 2017 Sep 27.
Retinitis Pigmentosa (RP) is a group of diseases in which one of a large number of mutations causes death of rod photoreceptors. After rods die, cone photoreceptors slowly degenerate in a characteristic pattern. The mechanism of rod cell death varies depending upon the gene that is mutated and the rate that rods degenerate is an important prognostic feature, because cones do not begin to degenerate until almost all rods have been eliminated. Rod cell death causes night blindness, but visual disability and blindness result from cone degeneration and therefore it is critical to determine the mechanisms by which it occurs. The death of rods reduces oxygen consumption resulting in high tissue levels of oxygen in the outer retina. The excess oxygen stimulates superoxide radical production by mismatches in the electron transport chain in mitochondria and by stimulation of NADPH oxidase activity in cytoplasm. The high levels of superoxide radicals overwhelm the antioxidant defense system and generate more reactive species including peroxynitrite which is extremely damaging and difficult to detoxify. This results in progressive oxidative damage in cones which contributes to cone cell death and loss of function because drugs or gene transfer that reduce oxidative stress promote cone survival and maintenance of function. Compared with aqueous humor samples from control patients, those from patients with RP show significant elevation of carbonyl content on proteins indicating oxidative damage and a reduction in the ratio of reduced to oxidized glutathione indicating depletion of a major component of the antioxidant defense system from ongoing oxidative stress. The first step in clinical trials will be to identify doses of therapeutic agents that reverse these biomarkers of disease to assist in design of much longer trials with functional and anatomic endpoints.
色素性视网膜炎(RP)是一组疾病,其中大量突变之一导致视杆细胞死亡。视杆细胞死亡后,视锥细胞以特征性模式缓慢退化。视杆细胞死亡的机制取决于发生突变的基因,视杆细胞的退化速度是一个重要的预后特征,因为只有当几乎所有的视杆细胞都被消除后,视锥细胞才开始退化。视杆细胞死亡导致夜盲症,但视力障碍和失明是由于视锥细胞退化所致,因此确定其发生机制至关重要。视杆细胞的死亡减少了氧气消耗,导致外视网膜组织中的氧气水平升高。多余的氧气通过线粒体电子传递链中的错配和细胞质中 NADPH 氧化酶活性的刺激,刺激超氧自由基的产生。高水平的超氧自由基超过了抗氧化防御系统,并产生更多的活性物质,包括过氧亚硝酸盐,它极具破坏性且难以解毒。这导致视锥细胞的进行性氧化损伤,这对视锥细胞的死亡和功能丧失有贡献,因为减少氧化应激的药物或基因转移可促进视锥细胞的存活和功能维持。与对照患者的房水样本相比,RP 患者的蛋白质羰基含量明显升高,表明存在氧化损伤,并且还原型/氧化型谷胱甘肽的比值降低,表明抗氧化防御系统的主要成分因持续的氧化应激而耗竭。临床试验的第一步将是确定可逆转这些疾病生物标志物的治疗剂剂量,以帮助设计具有功能和解剖学终点的更长时间试验。